Literature DB >> 30559377

m6A modification controls the innate immune response to infection by targeting type I interferons.

Roni Winkler1, Ella Gillis1, Lior Lasman1, Modi Safra1, Shay Geula1, Clara Soyris1, Aharon Nachshon1, Julie Tai-Schmiedel1, Nehemya Friedman2,3, Vu Thuy Khanh Le-Trilling4, Mirko Trilling4, Michal Mandelboim2,3, Jacob H Hanna1, Schraga Schwartz1, Noam Stern-Ginossar5.   

Abstract

N6-methyladenosine (m6A) is the most common mRNA modification. Recent studies have revealed that depletion of m6A machinery leads to alterations in the propagation of diverse viruses. These effects were proposed to be mediated through dysregulated methylation of viral RNA. Here we show that following viral infection or stimulation of cells with an inactivated virus, deletion of the m6A 'writer' METTL3 or 'reader' YTHDF2 led to an increase in the induction of interferon-stimulated genes. Consequently, propagation of different viruses was suppressed in an interferon-signaling-dependent manner. Significantly, the mRNA of IFNB, the gene encoding the main cytokine that drives the type I interferon response, was m6A modified and was stabilized following repression of METTL3 or YTHDF2. Furthermore, we show that m6A-mediated regulation of interferon genes was conserved in mice. Together, our findings uncover the role m6A serves as a negative regulator of interferon response by dictating the fast turnover of interferon mRNAs and consequently facilitating viral propagation.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30559377     DOI: 10.1038/s41590-018-0275-z

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  132 in total

1.  HIV Evades Immune Surveillance by Methylation of Viral RNA.

Authors:  Li Wu
Journal:  Biochemistry       Date:  2019-03-20       Impact factor: 3.162

Review 2.  N6-methyladenosine modifications: interactions with novel RNA-binding proteins and roles in signal transduction.

Authors:  Jiaxin Chen; Xiao Fang; Pengcheng Zhong; Zhangfa Song; Xiaotong Hu
Journal:  RNA Biol       Date:  2019-05-26       Impact factor: 4.652

3.  A Unified Model for the Function of YTHDF Proteins in Regulating m6A-Modified mRNA.

Authors:  Sara Zaccara; Samie R Jaffrey
Journal:  Cell       Date:  2020-06-02       Impact factor: 41.582

4.  m6A Modification Prevents Formation of Endogenous Double-Stranded RNAs and Deleterious Innate Immune Responses during Hematopoietic Development.

Authors:  Yimeng Gao; Radovan Vasic; Yuanbin Song; Rhea Teng; Chengyang Liu; Rana Gbyli; Giulia Biancon; Raman Nelakanti; Kirsten Lobben; Eriko Kudo; Wei Liu; Anastasia Ardasheva; Xiaoying Fu; Xiaman Wang; Poorval Joshi; Veronica Lee; Burak Dura; Gabriella Viero; Akiko Iwasaki; Rong Fan; Andrew Xiao; Richard A Flavell; Hua-Bing Li; Toma Tebaldi; Stephanie Halene
Journal:  Immunity       Date:  2020-06-03       Impact factor: 31.745

5.  Innate Immune Responses and Pulmonary Diseases.

Authors:  Tao Liu; Siqi Liu; Xiaobo Zhou
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 6.  Regulation of Viral Infection by the RNA Modification N6-Methyladenosine.

Authors:  Graham D Williams; Nandan S Gokhale; Stacy M Horner
Journal:  Annu Rev Virol       Date:  2019-07-05       Impact factor: 10.431

7.  In Vitro Selection with a Site-Specifically Modified RNA Library Reveals the Binding Preferences of N6-Methyladenosine Reader Proteins.

Authors:  A Emilia Arguello; Robert W Leach; Ralph E Kleiner
Journal:  Biochemistry       Date:  2019-07-23       Impact factor: 3.162

8.  YTHDF2 Recognition of N1-Methyladenosine (m1A)-Modified RNA Is Associated with Transcript Destabilization.

Authors:  Kyung W Seo; Ralph E Kleiner
Journal:  ACS Chem Biol       Date:  2019-12-12       Impact factor: 5.100

9.  Enterotoxigenic Escherichia coli infection promotes enteric defensin expression via FOXO6-METTL3-m6A-GPR161 signalling axis.

Authors:  Xin Zong; Hong Wang; Xiao Xiao; Yu Zhang; Yuhan Hu; Fengqin Wang; Yizhen Wang; Zeqing Lu
Journal:  RNA Biol       Date:  2020-09-23       Impact factor: 4.652

Review 10.  Targeting the epigenetic regulation of antitumour immunity.

Authors:  Simon J Hogg; Paul A Beavis; Mark A Dawson; Ricky W Johnstone
Journal:  Nat Rev Drug Discov       Date:  2020-09-14       Impact factor: 84.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.